Calypso Biotech Alternatives & Competitors

12 companies similar to Calypso Biotech — An innovative leader in biopharmaceuticals, crafting valuable antibody solutions...

Longbio Pharma

A biotech to R&D innovative antibody/protein drugs of allergic and complement diseases.

2 Series B $100.00M

Biotechnology Pharmaceutical

Polymed Biopharmaceuticals

Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-...

2 Series A

Hangzhou, China

Biotechnology Pharmaceutical

Biond Biologics Ltd

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...

43 Series C $32.00M

Israel

Biotechnology Health Care +1

Reata Pharmaceuticals, Inc.

Changing the landscape in life-threatening diseases

127 Post-IPO Debt $2.00B

Plano, United States

Biopharma Biotechnology +1

Track all Calypso Biotech competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Biogenerics Pharma GmbH

Innovating biotechnology since 2010 from Redwood City, California

2 Debt Financing $4.66M

Biotechnology Pharmaceutical

XTL Biopharmaceuticals Ltd.

2 Post-IPO Equity $2.80M

Israel

Biotechnology Pharmaceutical +1

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

54 Series D $300.00M

Chicago, United States

Biopharma Biotechnology +3

Henlius

Reliable Quality · Affordable Innovation

492 Venture round $346.00M

Shanghai, China

Biotechnology Health Care +1

Cinclus Pharma

Developing effective treatment for gastric acid related diseases.

20 Venture round $490.00M

Stockholm, Sweden

Biotechnology Health Care +1

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...

2-10 Series A $18.50M

Biopharma Biotechnology +1

Panolos Bioscience

Frontrunner in structure-based protein design and development. Focused on multi-specific b...

7 Series A $20.00B

Hwaseong-si, Korea South

Biopharma Biotechnology +1

TRELYS

Driving innovation in biotechnology since 2012 with roots in San Francisco, California

Seed $2.58M

Biotechnology Life Sciences +1

About Calypso Biotech

Calypso Biotech is an innovative leader in biopharmaceuticals, established in 2013 in Geneva, Switzerland. The company emerged from Merck Serono, a global authority in autoimmune diseases and biologics. Backed by a 2.5 million euro seed fund managed by MS Ventures, Calypso Biotech is known for its skilled team and stra...

Taxonomy

Biopharmaceuticals, Antibody Solutions, Geneva, Switzerland, Merck Serono, Autoimmune Diseases, Biologics, MS Ventures, Drug Development, Scientific Network, Industry Network, Investment, Innovation, Startup, Biotech

Frequently Asked Questions

Companies similar to Calypso Biotech include Longbio Pharma, Polymed Biopharmaceuticals, Biond Biologics Ltd, Reata Pharmaceuticals, Inc., Biogenerics Pharma GmbH. They work in Biotechnology and Pharmaceutical and share Calypso Biotech's focus on drug development, autoimmune diseases and biopharmaceuticals.

Bounce Watch lists 12 companies that share Calypso Biotech's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Calypso Biotech and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Calypso Biotech Profile Longbio Pharma Alternatives Polymed Biopharmaceuticals Alternatives Biond Biologics Ltd Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Calypso Biotech on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.